In summary, our study reveals the novel oncogenic role of TAB182 in ESCC and avail useful insights into a probable function of the TAB182/FHL2/β-catenin molecular axis in ESCC cell stemness, invasiveness, and tumorigenicity. The gene discussed is FHL2; the disease is esophageal squamous cell carcinoma.